UK-based medical device manufacturer, Lumendi obtained the European CE-Mark for its DiLumen Endolumenal Interventional Platform (EIP) which is used as an endoscope accessory.
The first-ever 3D, color X-rays were tested on a human by New Zealand Scientists, using technology that promises to enhance medical diagnostics in oncology, cardiology, neurology and orthopedics.
The US-based RAZOR (Randomised Open versus Robotic Cystectomy) trial revealed that robotic surgery is equally effective as traditional open surgery in order to treat bladder cancer. The study was funded by the National Cancer Institute and the discovery was published in the Lancet.
EchoNous announced that it has been granted FDA 510(k) clearance for its EchoNous Vein ultrasound device which could improve peripheral IV catheter placements. This system could provide real-time clear mages of superficial and deeper veins.
Chronic Obstructive Pulmonary Disease (COPD) is defined as a condition which affects airways and alveoli, leading to the loss of lung function in a progressive manner. COPD is the fourth leading cause of death globally and has affected more than 200 million people throughout the world.
A research team from the University of California, Los Angeles, United States has revealed that deep learning (a form of AI) can distinctively increase microscopic resolutions in photos taken via smartphones.
Saving lives through accurate diagnosis followed by swift treatment is the major outcome of new and pioneering medical inventions and technologies. And it is encouraging to see that the healthcare industry is heading towards this goal. With this in mind, we have listed three medical advances which have helped to change the medical scenario throughout the world.
A shocking report revealed that patients with multiple stents or having longer stent greater than 31.5mm could be associated with high risk of mortality. Around 4.5% of patients died within a year of angioplasty. Death occurred in patients between the age group 35-75, where most of the people were elderly. Similarly, more patients who received metal stents had to be re-hospitalized, compared to those who received sophisticated drug-eluting stents.
The smart stent looks similar to most commercial stents and uses medical-grade stainless steel. The researcher remarked that the devices as the first angioplasty smart stent, can be implanted in the patients without any modification in current medical procedures.
Chief executive Dr. John Thompson, stated that the company also plans on targeting angel investors and a number of high-net-worth individuals in the new funding round. According to another report, AuriGen won a €2.5m funding boost from the EU-backed Horizon 2020 SME funding scheme amidst a lot of competition just last week.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.